Aclacinomycin X, a Novel Anthracycline Antibiotic Produced byStreptomyces galilaeusATCC 31133

Aclacinomycin X, a Novel Anthracycline Antibiotic Produced by<i>Streptomyces galilaeus</i>ATCC 31133 Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties. New Anthracycline Metabolites Produced by the Aklavinone 11-Hydroxylase Gene in Streptomyces galilaeus ATCC 31133. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. II. Structural determination. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity. MICROBIAL CONVERSION OF ANTHRACYCLINE ANTIBIOTICS I. MICROBIAL CONVERSION OF ACLACINOMYCIN BTO ACLACINOMYCIN A New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides. New anthracycline antibiotics, rhodirubins. Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus